Amphotericin B as a potentiation agent to cytotoxic chemotherapy
- 29 February 1988
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (2) , 117-121
- https://doi.org/10.1016/0277-5379(88)90241-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Amphotericin B renders stationary phase hepatoma cells sensitive to dipyridamoleBiochemical and Biophysical Research Communications, 1986
- Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomasEuropean Journal of Cancer and Clinical Oncology, 1986
- Effects of amphotericin B on combination chemotherapy of metastatic sarcomasCancer, 1984
- Antifungal Agents Useful in Therapy of Systemic Fungal InfectionsAnnual Review of Pharmacology and Toxicology, 1983
- Amphotericin B (Fungizone®) enhancement of nitrogen mustard uptake by human tumor cellsBiochemical and Biophysical Research Communications, 1980
- Response of Transplanted AKR Leukemia to Combination Therapy With Amphotericin Band 1,3-Bis(2-chloroethyl)-1-nitrosourea: Dose and Schedule Dependency2JNCI Journal of the National Cancer Institute, 1977
- Polyene Potentiation of Antitumor Agents2JNCI Journal of the National Cancer Institute, 1973